Finance

Lists
1789:TPE
ScinoPharm Taiwan Ltd
NT$18.95
+1.61%
(+0.30) 1D
Oct 7, 1:30:09 PM GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 1789...
Open
NT$18.65
High
NT$19.00
Low
NT$18.65
Mkt. cap
14.98B
Avg. vol.
415.96K
Volume
328.73K
Dividend
1.53%
Quarterly dividend
NT$0.07
Ex-dividend date
Jul 2, 2026
P/E ratio
398.28
52-wk high
NT$29.10
52-wk low
NT$16.70
EPS
NT$0.05
Shares outstanding
790.74M
No. of employees
1K
Open
NT$18.65
High
NT$19.00
Low
NT$18.65
Mkt. cap
14.98B
Avg. vol.
415.96K
Volume
328.73K
Dividend
1.53%
Quarterly dividend
NT$0.07
Ex-dividend date
Jul 2, 2026
P/E ratio
398.28
52-wk high
NT$29.10
52-wk low
NT$16.70
EPS
NT$0.05
Shares outstanding
790.74M
No. of employees
1K
News stories
From web sources and news partners
About ScinoPharm Taiwan Ltd
CEO-
Employees1.01K
FoundedNov 11, 1997
Headquarters-
SectorPharmaceutical industry
Websitescinopharm.com
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
721.50M
1.01B
659.71M
678.50M
Cost of goods sold
505.66M
674.97M
438.17M
543.87M
Cost of revenue
505.66M
674.97M
438.17M
543.87M
Research and development expenses
121.40M
195.17M
85.54M
86.45M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
114.03M
128.12M
112.89M
113.74M
Operating expense
235.45M
325.04M
213.05M
200.04M
Total operating expenses
741.11M
1.00B
651.22M
743.91M
Operating income
-19.62M
8.03M
8.49M
-65.41M
Other non operating income
-9.89M
19.92M
-7.76M
3.85M
EBT including unusual items
19.18M
23.96M
19.32M
-53.50M
EBT excluding unusual items
19.28M
21.96M
19.35M
-53.42M
Income tax expense
3.73M
-17.32M
2.80M
-17.98M
Effective tax rate
19.46%
-72.27%
14.47%
33.60%
Other operating expenses
-
-
-
-
Net income
15.45M
41.28M
16.53M
-35.53M
Net profit margin
2.14%
4.10%
2.51%
-5.24%
Earnings per share
0.02
0.05
-
-
Interest and investment income
37.62M
-
13.03M
14.10M
Interest expense
-2.71M
-16.12M
-2.97M
-3.06M
Net interest expenses
34.92M
-16.12M
10.06M
11.05M
Depreciation and amortization charges
-
-
-
-
EBITDA
105.83M
134.08M
133.63M
55.46M
Gain or loss from assets sale
100.00K
188.00K
21.00K
88.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps